Minireview: Sex differentiation

Endocrinology

Volumn 142, Issue 8, 2001, Pages 3281-3287

  Hughes, Ieuan A ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; INSULIN; MUELLERIAN INHIBITING FACTOR; WNT PROTEIN;

GENE EXPRESSION REGULATION; HORMONE DEPENDENCE; LEYDIG CELL; MAMMAL; MUELLERIAN DUCT; OVARY; PRIORITY JOURNAL; SEX DETERMINATION; SEX DIFFERENTIATION; SEX DIFFERENTIATION DISORDER; SHORT SURVEY; SIGNAL TRANSDUCTION; TESTIS;

EID: 0034925004     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.142.8.8406     Document Type: Short Survey

References (97)

1. Recherches sur le differentiation sexuelle de l'embryon de lapin III. Rôle des gonades foetales dans la differentiation sexuelle somatique
2. Problems of fetal endocrinology: The gonadal and hypophyseal hormones
3. Familial sex reversal: A review
4. Genetic basis of sex determination and sex differentiation
5. The origin and migration of primordial germ cells in the mouse
6. Germ cells
7. Differentiation of the fetal gonad
8. Fetal testis - A very special endocrine organ
9. Human fetal testis: Second trimester proliferative and steroidogenic capacities
10. A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the Müllerian duct
11. Molecular mechanisms of hormone-mediated Mullerian duct regression: Involvement β-catenin
12. 17β-hydroxysteroid dehydrogenase-3 deficiency: Diagnosis, phenotypic variability, population genetics, and worldwide distribution of ancient and de novo mutations
13. Tissue distribution and ontogeny of steroid 5α-reductase isozyme expression
14. Steroid 5α-reductase deficiency
15. Estrogen receptor null mice: What have we learned and where will they lead us?
16. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man
17. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens
18. Evidence for evolutionary conservation of sex-determining genes
19. Sry and SOX9: Mammalian testis-determination genes
20. Mammalian sex determination: A molecular drama
21. The battle of the sexes
22. Hormones in male sexual development
23. A transgenic insertion upstream of SOX9 is associated with dominant XX sex reversal in the mouse
24. Candidate genes in complete and partial XY sex reversal: Mutation analysis of SRY, SRY-related genes and FTZ-F1
25. Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene
26. Evidence to exclude SOX9 as a candidate gene for XY sex reversal without skeletal malformation
27. A heuristic approach of maximum likelihood method for inferring phylogenetic tree and an application to the mammalian SOX-3 origin of the testis-determining gene SRY
28. Mutation analysis of subjects with 46,XX sex reversal and 46,XY gonadal dysgenesis does not support the involvement of SOX3 in testis determination
29. 2+-binding protein, Col9a3, and renin are expressed in the mouse testis during the early stages of gonadal differentiation
30. Deletion 9p and sex reversal
31. Dmrt1, a gene related to worm and fly sexual regulators, is required for mammalian testis differentiation
32. A region of human chromosome 9p required for testis development contains two genes related to known sexual regulators
33. The human doublesex-related gene, DMRT2, is homologous to a gene involved in somatogenesis and encodes a potential bicistronic transcript
34. Writ signalling: A common theme in animal development
35. Molecular genetic studies of Wnt signalling in the mouse
36. Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4
37. Female development in mammals is regulated by Wnt-4 signalling
38. Sexually dimorphic development of the mammalian reproductive tract requires Wnt-7a
39. Wnt-7a maintains appropriate uterine patterning during the development of the mouse female reproductive tract
40. New insights into Müllerian inhibiting substance and its mechanism of action
41. TGF-β signal transduction
42. Engagement of bone morphogenetic protein type IB receptor and Smad1 signalling by anti-Múllerian hormone and its type II receptor
43. Clinical aspects and molecular genetics of the persistent Múllerian duct syndrome
44. Persistence of Müllerian ducts in males
45. Múllerian inhibiting substance function during mammalian sexual development
46. Genetic analysis of the Mullerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation
47. Sexual differentiation and environmental endocrine disruptors
48. Androgen action during male sex differentiation includes suppression of cranial suspensory ligament development
49. Targeted disruption of the Insl3 gene causes bilateral cryptorchidism
50. Cryptorchidism in mice mutant for Insl 13
51. A common polymorphism in the human relaxin-like factor (RLF) gene: No relationship with cryptorchidism
52. Insulin-like 3/relaxin-like factor gene mutations are associated with cryptorchidism
53. Genetic analysis of the INSL3 gene in patients with maldescent of the testis
54. Testicular position in the androgen insensitivity syndrome: Implication of the role of androgens in testicular descent
55. Clinical and molecular evidence for the role of androgens and WT1 in testis descent
56. Maternal hormone levels in early gestation of cryptorchid males: A case control study
57. Involvement of insulin-like factor 3 (Insl3) in diethylstilbestrol-induced cryptorchidism
58. A molecular basis for estrogen-induced cryptorchidism
59. Gonadotropin receptors and the control of gonadal steroidogenesis: Physiology and pathology
60. Studies on the regulation of testosterone synthesis in the fetal rabbit testis
61. Normal prenatal but arrested postnatal sexual development of luteinizing hormone receptor knockout (LuRKO) mice
62. Targeted disruption of luteinizing hormone/human chorionic gonadotropin receptor gene
63. Mutations of gonadotropins and gonadotropin receptors: Elucidating the physiology and pathophysiology of pituitary-gonadal function
64. The 3β-hydroxysteroid dehydrogenase gene family of enzymes
65. Steroid 5α-reductase: Two genes/two enzymes
66. Role of the acute regulatory protein StAR in steroidogenesis
67. 17β-hydroxysteroid dehydrogenase 3 deficiency
68. Early steps in androgen biosynthesis: From cholesterol to DHEA
69. Natural potent androgens: Lessons from human genetic models
70. Diagnosis and treatment of disorders of sexual development
71. Molecular mechanisms of steroid hormone action
72. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain effect transactivation function
73. Nuclear receptor coregulators: Cellular and molecular biology
74. Nuclear hormone receptor coregulators in action: Diversity for shared tasks
75. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily
76. Structure and specificity of nuclear receptor-coactivator interactions
77. Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization
78. The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1
79. A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex
80. Cloning and characterisation of a specific co-activator, ARA 70, for the androgen receptor in human prostate cells
81. Androgen receptor defects: Historical, clinical and molecular perspectives
82. Phenotypic features, androgen receptor binding and mutational analysis in 278 clinical cases reported as androgen insensitivity syndrome
83. Two cases of male infertility associated with missense mutations in the androgen receptor gene
84. The androgen receptor gene mutations database
85. Structural evidence for ligand specificity in the binding domain of the human androgen receptor
86. Specific recognition of androgens by their nuclear receptors
87. Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene
88. Resistance to several steroids in two sisters
89. Androgen-insensitivity syndrome as a possible coactivator disease
90. A novel explanation for resistance to androgens
91. Genetic evidence to exclude the androgen receptor co-factor, ARA 70 (NCOA4) as a candidate gene for the causation of undermasculinised genitalia
92. Long polyglutamine tracts in the androgen receptor are associated with reduced transactivation, impaired sperm production and male infertility
93. Linkage between male infertility and trinucleotide repeat expansion in the androgen receptor gene
94. Longer polyglutamine tracts in the androgen receptor are associated with moderate to severe undermasculinized genitalia in XY males
95. Evidence that longer androgen receptor polyglutamine repeats are a causal factor for genital abnormalities